2Raghu G, Collard H, Egan J J, et al.An official ATS,rERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management[J].Am Jrespir Crit Care Med, 2011, 183 ( 2 ) : 788-824.
3Navaratnam V, Fleming K M, West J, et al.The rising incidence of idiopathic pulmonary fibrosis in the UK[J].Thorax, 2011, 66 (2) : 462-467.
4Bhah N, Baran C P, Allen J, et al.Promising phaermacologic innovation in treating pulmonary fibrosis[J].Respiration, 2004, 71( 6 ): 656-657.
5Yamaki K, Thorlacius H, Xie X, et al.Charaacteristics of histamine- induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery[J].Br J Pharmacol, 1998, 123 ( 3 ) : 390.
6Benbarek H, Mouithys-Mickalad A, Deby-Dupont G, et al.High con centrations of histamine stimulate equine polymprphonuclear neutmphils to produce reactive oxygen[J].Species Res, 1999, 48 ( 11 ) : 594.
7Kroegel C, Mock B, Hengst U, et al.Interferon-gamma-lb, therapeutic option in avanced idiopathic pulmonary fibrosis[J]. Respiration, 2004, 71 (6) : 656-657.
8Shimizu T, Nishihira J, Watanabe H, et al. Cetirizine, an Hi-receptor antagonist inhibitory factor: its potenial anti-inflammatory action[J]. Clin Exp Allergy, 2004, 34 ( 1 ) : 103.
